自体毛乳头鞘杯细胞治疗雄性与女性型脱发的随机安慰剂对照剂量探索研究
结果示3.0×10^5 DSC细胞注射部位在6和9个月时总毛发密度与累积毛发直径较安慰剂显著增加,男女改善相似,无严重不良事件。
要点
- 3.0×10^5 DSC细胞注射在6和9个月时显著增加毛发密度与直径。
- 男性和女性型脱发患者改善程度相似。
- 治疗总体安全,未报告严重不良事件。
核心结论
- 自体DSC细胞疗法可能成为治疗MPHL和FPHL的新方法。
主要发现
- 3.0×10^5 DSC细胞注射部位在6和9个月时总毛发密度与累积毛发直径较安慰剂显著增加。
- 男性和女性改善相似,无严重不良事件。
关键数值与推荐
- 3.0×10^5 DSC细胞剂量在6和9个月时显示显著优于安慰剂的毛发密度与直径改善。
临床怎么用
- 自体DSC细胞单次注射可能作为MPHL和FPHL的新治疗选择,但效果在9个月后暂时性消失。
局限性
- 未测试更低细胞数量,阳性效果仅暂时维持至9个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few effective treatments are available for male pattern hair loss (MPHL) or, especially, for female pattern hair loss (FPHL). Recently, cell-based therapies using autologous or allogeneic cells have been used clinically. OBJECTIVE: We examined the safety and efficacy of autologous cell-based therapy using dermal sheath cup (DSC) cells to treat MPHL and FPHL. METHODS: DSCs dissected from occipital hair follicles were cultured to manufacture DSC cells. Participants with MPHL or FPHL received single injections of 7.5 × 106, 1.5 × 106, or 3.0 × 105 DSC cells or a placebo in 4 randomized separate regions on the scalp, and hair densities and diameters were measured for 3, 6, 9, and 12 months. RESULTS: Fifty men and 15 women aged 33 to 64 years were injected with DSC cells. Total hair density and cumulative hair diameter at the 3.0 × 105 DSC cells injection site was significantly increased compared with the placebo after 6 and 9 months. Men and women showed similar improvements, and there were no serious adverse events. LIMITATIONS: No lower cell numbers were tested, and the positive effect was temporary until 9 months. CONCLUSION: The results suggest that cell therapy with autologous DSC cells may be useful as a new therapeutic method for treating MPHL and FPHL.
引用
- Tsuboi R, Niiyama S, Irisawa R, et al. Autologous cell-based therapy for male and female pattern hair loss using dermal sheath cup cells: A randomized placebo-controlled double-blinded dose-finding clinical study. J Am Acad Dermatol. 2020. PMID: 32147390. doi:10.1016/j.jaad.2020.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。